Healthcare / Health Information ServicesNasdaqCM
$0.78
+0.01 (+1.09%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 33% · confianza 25%
FCF escenarios
weak_data · normalized FCF $-7.0M · quality 69.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
33/100
D
Piotroski
3/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
20/100
SEC 0%
Sin guardar todavía.
Market Cap
$42M
P/E
N/A
•EV/EBITDA
N/A
•ROE
94.5%
↑Gross Margin
-37.0%
↓Debt/Equity
-0.19
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2021–2025 · 4 años de histórico normalizado
Revenue CAGR
—
FCF CAGR
—
FCF margin
-553.1%
FCF / Net income
2.68x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $1.4M · net income $-2.8M · FCF $-7.5M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | $1.4M | $1.4M | $643000.00 | $1.0M | $1.2M | — |
| Net Income | $-2.8M | $-2.8M | $-10.1M | $-33.8M | $-30.5M | $5.1M |
| EBITDA | $-2.7M | $-2.7M | $-9.9M | $-33.7M | $-30.4M | — |
| EPS | — | — | -0.36 | -4.65 | -7.55 | 0.44 |
| Gross Margin | -37.0% | -37.0% | -43.7% | -12.6% | -31.2% | — |
| Operating Margin | -711.3% | -711.3% | -1493.8% | -671.2% | -1369.3% | — |
| Net Margin | -206.1% | -206.1% | -1575.3% | -3308.5% | -2641.0% | — |
| Balance Sheet | ||||||
| Debt/Equity | -0.19 | -0.19 | -0.55 | -0.38 | -1.00 | — |
| Current Ratio | 0.27 | 0.27 | — | — | — | — |
| Cash Flow | ||||||
| Free Cash Flow | $-7.5M | $-7.5M | $-7.0M | $-4.8M | $-4.8M | — |
| Returns | ||||||
| ROE | 94.5% | 94.5% | 63.5% | 251.3% | 115.5% | -72.8% |
| Growth & Yield | ||||||
| Revenue Growth | 111.4% | 111.4% | -37.0% | -11.4% | — | — |
| EPS Growth | — | — | 92.3% | 38.4% | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+94.8%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.36 → n/d
Residual
+94.8%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.